Reaction

Diabetic Foot reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,025 reports · 56 co-occurring drugs

As of the last recalculation, Diabetic Foot appears in 3,025 FAERS reports alongside 56 co-occurring drug terms. The strongest observed disproportionality signal is CANAGLIFLOZIN (PRR 244.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Canagliflozin	788	244.7	251.3
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	124	108.5	110.2
Insulin Glargine-Yfgn	82	26.5	26.6
Insulin Glulisine	32	21.9	21.9
Erythropoietin	56	19.1	19.1
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	80	18.2	18.2
Insulin Human	98	17.5	17.5
Paricalcitol	31	15.2	15.3
Human Insulin	27	15.0	15.0
Insulin	108	13.8	13.8
Insulin Aspart	124	13.4	13.4
Eplerenone	24	13.0	13.0
Insulin Degludec	40	11.9	11.9
Insulin Glargine	357	11.2	11.2
Ranibizumab	41	10.8	10.8
Ziprasidone Mesylate	19	9.2	9.2
Empagliflozin	83	8.7	8.7
Insulin Lispro	163	8.5	8.5
Ziprasidone	20	7.9	7.9
Torsemide	37	7.8	7.8
Indapamide	18	6.9	7.0
Calcitriol Capsules 0.25 Mcg	20	6.9	6.9
Calcitriol Capsules 0.5 Mcg	20	6.9	6.9
Calcitriol	20	6.8	6.8
Linagliptin	17	6.4	6.4
Primidone	9	6.1	6.1
Glipizide	53	6.1	6.1
Dapagliflozin	27	6.0	6.0
Olanzapine Pamoate	35	5.9	5.9
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide	25	5.7	5.7
Amitriptyline Hydrochloride	14	5.5	5.5
Gemfibrozil	12	5.5	5.5
Metformin Er 500 Mg	221	5.4	5.4
Metformin Er 750 Mg	221	5.4	5.4
Cyclobenzaprine Hydrochloride	7	5.4	5.4
Metformin	248	5.1	5.1
Dutasteride	6	5.1	5.1
Methoxy Polyethylene Glycol-Epoetin Beta	8	5.0	5.0
Glyburide	17	4.9	4.9
Nilotinib	20	4.7	4.7
Terazosin Hydrochloride	6	4.6	4.7
Amlodipine Besylate And Valsartan	7	4.4	4.4
Isosorbide Mononitrate	13	4.3	4.3
Pioglitazone	25	4.0	4.0
Sitagliptin And Metformin Hydrochloride	12	3.8	3.8
Metformin Hcl	28	3.5	3.5
Liraglutide	25	3.5	3.5
Rifaximin	10	3.3	3.3
Dulaglutide	41	3.2	3.2
Ranolazine	4	2.6	2.6
Sevelamer Carbonate	4	2.4	2.4
Exenatide	17	2.2	2.2
Umeclidinium Bromide And Vilanterol Trifenatate	5	2.1	2.1
Tafamidis	3	1.8	1.8
Sacubitril And Valsartan	27	1.6	1.6
Bimekizumab	4	1.3	1.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.